Effect of Premeal Protein-bar on Glycemic Control in Patients With Type 2 Diabetes
NCT ID: NCT03727854
Last Updated: 2020-04-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2018-08-27
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Premeal Consumption of Protein-enriched Bar on Blood Glucose Level and Secretion of Hormones
NCT02589028
Effect of Varying the Protein and Dietary Fiber Content of Energy Bars on Their Glycemic and Insulinemic Impact
NCT02537587
The Effect of Dietary Fiber-enriched Cereals on Glycemic Control and Secretion of Gut Hormones
NCT01997281
Multiple Grain in Type 2 Diabetes
NCT00337337
Food Containing Resistant Starch Type 4 and Postprandial Glycemic Response
NCT03844503
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Premeal protein group
Premeal protein enriched bar with dietary modification
Premeal protein enriched bar
Subjects in the intervention group will intake protein enriched bar 15 minutes before each meals (at least twice a day).
Dietary modification
Subjects in this group will follow diabetes diet education.
Dietary modofication only group
Dietary modification only
Dietary modification
Subjects in this group will follow diabetes diet education.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Premeal protein enriched bar
Subjects in the intervention group will intake protein enriched bar 15 minutes before each meals (at least twice a day).
Dietary modification
Subjects in this group will follow diabetes diet education.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Type 2 diabetes patients
* Fasting blood glucose ≥ 126 mg/dl or
* HbA1c ≥ 6.5% or
* Subjects who were previously diagnosed with type 2 diabetes and who have been treated with lifestyle modification only, oral anti-diabetic drugs or basal insulin.
Exclusion Criteria
* Subjects using insulin other than basal insulin
* Subjects who have newly started or have changed anti diabetic drugs within 3 months
* Subjects who are allergic to grains, nuts, legumes and milk
* Previous history of gastrointestinal surgery (except for hemorrhoid surgery, appendectomy surgery and hernia surgery)
* Subjects with chronic unstable disease
* Subjects with cognitive impairments who are not able to follow the study protocol
* Females who are pregnant or doing breast feeding
* Subjects with Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) levels of higher than 3 times of upper normal ranges
* Subjects with hemoglobin level of less than 10.0 g/dL
* Subjects with alcohol addiction or drug abuse
19 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Young Min Cho
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Young Min Cho, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-1804-120-940
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.